Literature DB >> 27641423

Long-term remission of acquired von Willebrand syndrome associated with multiple myeloma using bortezomib and dexamethasone therapy.

S Katagiri1, D Akahane1, K Amano2, K Ohyashiki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27641423     DOI： 10.1111/hae.13077

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  4 in total

1.  Successful treatment of acquired von Willebrand syndrome associated with monoclonal gammopathy : Breaking a dangerous bond.

Authors:  Georg Jeryczynski; Hermine Agis; Sabine Eichinger-Hasenauer; Maria Theresa Krauth
Journal:  Wien Klin Wochenschr       Date:  2022-03-19       Impact factor: 2.275

2.  Acquired von Willebrand syndrome and lymphoproliferative disorders: A case report.

Authors:  Christophe Nicol; Leela Raj; Gaëlle Guillerm; Francis Couturaud; Jean-Richard Eveillard; Brigitte Pan-Petesch
Journal:  Clin Case Rep       Date:  2020-03-09

3.  Combined Coagulopathy Can Induce Both Hemorrhagic and Thrombotic Complications in Multiple Myeloma.

Authors:  Ichiro Kawashima; Katsuhiro Takano; Takuma Kumagai; Megumi Koshiishi; Saori Oishi; Yuki Sueki; Kei Nakajima; Toru Mitsumori; Keita Kirito
Journal:  Intern Med       Date:  2018-07-06       Impact factor: 1.271

4.  Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient.

Authors:  Matthias Höpting; Ulrich Budde; Andreas Tiede; Matthias Grube; Joachim Hahn; Wolfgang Herr; Susanne Heimerl; Christina Hart
Journal:  Acta Haematol       Date:  2022-01-27       Impact factor: 3.068
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.